Patents by Inventor Thierry Prud'homme

Thierry Prud'homme has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9242038
    Abstract: A diabetes therapy device is disclosed herein, which includes a profile memory storing a parameter profile and a dedicated reference time mark. The parameter profile defines at least one parameter that is associated with insulin administration as a function of time for a generally circadian chronobiological cycle. The reference time mark indicates the beginning of the circadian chronobiological cycle and initializes a running time. Insulin amounts to be administered are determined as a function of the running time in accordance with a current matching of the parameter profile. A modified matching based on the reference time mark and an upcoming trigger time is computed and is time-shifted from the current matching, wherein the modified matching is applied by making the modified matching the current matching, such that future insulin amounts to be administered are determined in accordance with the modified matching.
    Type: Grant
    Filed: September 23, 2010
    Date of Patent: January 26, 2016
    Assignee: Roche Diagnostics International AG
    Inventors: Gilles Prod'hom, Thierry Prud'homme, Robert Hellwig, Bernhard Teupe
  • Patent number: 8527208
    Abstract: A method and system for optimizing post prandial blood glucose excursions for persons with diabetes via computation of time-varying optimal insulin profiles are disclosed. The method builds upon a mathematical model based on the physiologic description of the human glucoregulatory system. Model parameter values are specific for each patient and meal type, and are determined from measured data by minimizing differences between both measurements and model predictions, and which are used to provide the optimal insulin profiles that are useful to diabetics in managing their chronic disease.
    Type: Grant
    Filed: November 17, 2008
    Date of Patent: September 3, 2013
    Assignee: Roche Diagnostics International AG
    Inventors: Thierry Prud'homme, Catalin Cris
  • Publication number: 20110238033
    Abstract: A diabetes therapy device is disclosed herein, which includes a profile memory storing a parameter profile and a dedicated reference time mark. The parameter profile defines at least one parameter that is associated with insulin administration as a function of time for a generally circadian chronobiological cycle. The reference time mark indicates the beginning of the circadian chronobiological cycle and initializes a running time. Insulin amounts to be administered are determined as a function of the running time in accordance with a current matching of the parameter profile. A modified matching based on the reference time mark and an upcoming trigger time is computed and is time-shifted from the current matching, wherein the modified matching is applied by making the modified matching the current matching, such that future insulin amounts to be administered are determined in accordance with the modified matching.
    Type: Application
    Filed: September 23, 2010
    Publication date: September 29, 2011
    Applicant: ROCHE DIAGNOSTICS INTERNATIONAL AG
    Inventors: Gilles Prod'hom, Thierry Prud'homme, Robert Hellwig, Bernhard Teupe
  • Publication number: 20100125241
    Abstract: A method and system for optimizing post prandial blood glucose excursions for persons with diabetes via computation of time-varying optimal insulin profiles are disclosed. The method builds upon a mathematical model based on the physiologic description of the human glucoregulatory system. Model parameter values are specific for each patient and meal type, and are determined from measured data by minimizing differences between both measurements and model predictions, and which are used to provide the optimal insulin profiles that are useful to diabetics in managing their chronic disease.
    Type: Application
    Filed: November 17, 2008
    Publication date: May 20, 2010
    Applicant: DISETRONIC LICENSING, AG
    Inventors: Thierry Prud'homme, Catalin Cris